OCT East Asia 2024

Event description:

Novotech is attending the 9th Annual Outsourcing in Clinical Trials (OCT) East Asia, held at the JW Marriott in Seoul. This event is a leading platform for clinical outsourcing in East Asia, bringing together over 250 senior industry decision-makers to tackle operational and outsourcing challenges within clinical trials. 

Visit Booth #28 to connect with Dr. Yooni Kim, Managing Director - Asia Pacific; Lilian Kim, Senior Director of Business Development; Chris Chong, Senior Director of Clinical Services; Hyun Kim, Project Director; and the Korean Business Development team. Our experts are ready to discuss how Novotech’s experience and tailored solutions can help drive your clinical development goals in the APAC region. 

Don’t miss these key sessions by Novotech experts: 

“Post-pandemic: Strategies to Advance Your Journey in Vaccine Development” 

Presenter: Chris Chong, Senior Director of Clinical Services 

Date: December 3, 2024 

Time: 10:15 - 10:45 am KST 

Key Topics: 

• Trends in the vaccine trials landscape 
• Leveraging Southeast Asia in vaccine development 
• A case study on expediting clinical development in a multi-regional vaccine study 

“Setting up Global Clinical Trials, with a Focus on Asia Pacific” 

Panel Discussion featuring Hyun Kim, Project Director 

Date: December 4, 2024 

Time: 12:15 - 1:00 pm KST 

Key Topics: 

• Opportunities in Asia: Benefits and considerations for selecting Asian nations as trial locations. 
• Regulatory Challenges: Navigating diverse notified bodies and their impact on clinical execution strategies. 
• Compliance Insights: Understanding distinct regulatory frameworks and prerequisites for clinical trials. 

Join us at OCT East Asia to gain insights from industry leaders, engage in roundtable discussions, and explore strategies for enhancing clinical operations and partnerships across East Asia’s evolving clinical trials landscape. 

We look forward to connecting with you at Booth #28.